Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Receivables: 2019-2022

Historic Receivables for Bicycle Therapeutics (BCYC) over the last 4 years, with Dec 2022 value amounting to $21.2 million.

  • Bicycle Therapeutics' Receivables was N/A to $46.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $227.5 million, marking a year-over-year change of. This contributed to the annual value of $21.2 million for FY2022, which is 78.06% up from last year.
  • Per Bicycle Therapeutics' latest filing, its Receivables stood at $21.2 million for FY2022, which was up 78.06% from $11.9 million recorded in FY2021.
  • Bicycle Therapeutics' Receivables' 5-year high stood at $21.2 million during FY2022, with a 5-year trough of $201,000 in FY2019.
  • Moreover, its 3-year median value for Receivables was $14.6 million (2020), whereas its average is $15.9 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Receivables soared by 7,180.10% in 2020 and then declined by 18.61% in 2021.
  • Bicycle Therapeutics' Receivables (Yearly) stood at $201,000 in 2019, then soared by 7,180.10% to $14.6 million in 2020, then decreased by 18.61% to $11.9 million in 2021, then spiked by 78.06% to $21.2 million in 2022.